Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Report 2017
- QYR937019
- 118 Pages
- February 2017
- Materials and Chemicals
Sales, means the sales volume of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Revenue, means the sales value of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
This report studies sales (consumption) of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Bayer HealthCare
AngioCure
AVIDAL Vascular GmbH
AnGes MG
Contego Medical
Elixir Medical
eucatech AG
Lifetech Scientific
Medtronic
Micell Technologies
Nipro
NuVascular Technologies
QT Vascular
QualiMed Innovative Medizinprodukte GmbH
Rontis
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on sales, market share and growth rate of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons in each application, can be divided into
Application 1
Application 2
Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Report 2017
1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Overview
1.1 Product Overview and Scope of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
1.2 Classification of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
1.2.1 Type I
1.2.2 Type II
1.3 Application of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
1.3.1 Application 1
1.3.2 Application 2
1.4 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (2012-2022)
1.5.1 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2022)
1.5.2 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2022)
2 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Manufacturers, Type and Application
2.1 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Competition by Manufacturers
2.1.1 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume and Value) by Type
2.2.1 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type (2012-2017)
2.2.2 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Type (2012-2017)
2.3 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume and Value) by Countries
2.3.1 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Countries (2012-2017)
2.4 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume) by Application
3 Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume, Value and Sales Price)
3.1 Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
3.1.1 Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
3.1.2 Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
3.1.3 Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
3.2 Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
3.3 Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
3.4 Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application
4 France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume, Value and Sales Price)
4.1 France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
4.1.1 France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
4.1.2 France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
4.1.4 France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
4.2 France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
4.3 France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
4.4 France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application
5 UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume, Value and Sales Price)
5.1 UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
5.1.1 UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
5.1.2 UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
5.1.5 UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
5.2 UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
5.3 UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
5.4 UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application
6 Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume, Value and Sales Price)
6.1 Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
6.1.1 Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
6.1.2 Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
6.1.6 Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
6.2 Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
6.3 Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
6.4 Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application
7 Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume, Value and Sales Price)
7.1 Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
7.1.1 Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
7.1.2 Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
7.1.7 Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
7.2 Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
7.3 Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
7.4 Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application
8 Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume, Value and Sales Price)
8.1 Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
8.1.1 Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
8.1.2 Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
8.1.8 Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
8.2 Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
8.3 Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
8.4 Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application
9 Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume, Value and Sales Price)
9.1 Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
9.1.1 Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
9.1.2 Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
9.2 Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
9.3 Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
9.4 Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application
10 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Manufacturers Analysis
10.1 Bayer HealthCare
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Bayer HealthCare Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 AngioCure
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 AngioCure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 AVIDAL Vascular GmbH
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 AVIDAL Vascular GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 AnGes MG
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 AnGes MG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Contego Medical
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Contego Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Elixir Medical
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Elixir Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 eucatech AG
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 eucatech AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Lifetech Scientific
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Lifetech Scientific Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Medtronic
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Medtronic Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Micell Technologies
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Micell Technologies Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Nipro
10.12 NuVascular Technologies
10.13 QT Vascular
10.14 QualiMed Innovative Medizinprodukte GmbH
10.15 Rontis
11 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Manufacturing Cost Analysis
11.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Forecast (2017-2022)
14.1 Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast (2017-2022)
14.2 France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast (2017-2022)
14.3 UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast (2017-2022)
14.4 Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast (2017-2022)
14.5 Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast (2017-2022)
14.6 Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast (2017-2022)
14.7 Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast (2017-2022)
14.8 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Type (2017-2022)
14.9 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Table Classification of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Figure Europe Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Figure Europe Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2022)
Figure France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2022)
Figure UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2022)
Figure Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2022)
Figure Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2022)
Figure Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2022)
Figure Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2022)
Figure Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2022)
Figure Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2022)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales of Key Manufacturers (2015 and 2016)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Manufacturers
Figure 2016 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Manufacturers
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue by Manufacturers (2015 and 2016)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Manufacturers
Table 2016 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Manufacturers
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Type (2012-2017)
Figure Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Type (2012-2017)
Figure Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Growth Rate by Type (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Type (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Type (2012-2017)
Figure Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Growth Rate by Type (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Countries (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Countries (2012-2017)
Figure Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Countries (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Countries (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Countries (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Application (2012-2017)
Figure Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Application (2012-2017)
Figure Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2015 and 2016)
Table Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2015 and 2016)
Table Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2015 and 2016)
Table Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2015 and 2016)
Table Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2015 and 2016)
Table Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2015 and 2016)
Figure France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2015 and 2016)
Table France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2015 and 2016)
Table France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2015 and 2016)
Table France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2015 and 2016)
Table France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2015 and 2016)
Table France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2015 and 2016)
Figure UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2015 and 2016)
Table UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2015 and 2016)
Table UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2015 and 2016)
Table UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2015 and 2016)
Table UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2015 and 2016)
Table UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2015 and 2016)
Figure Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2015 and 2016)
Table Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2015 and 2016)
Table Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2015 and 2016)
Table Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2015 and 2016)
Table Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2015 and 2016)
Table Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2015 and 2016)
Figure Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2015 and 2016)
Table Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2015 and 2016)
Table Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2015 and 2016)
Table Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2015 and 2016)
Table Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2015 and 2016)
Table Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2015 and 2016)
Figure Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2015 and 2016)
Table Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2015 and 2016)
Table Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2015 and 2016)
Table Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2015 and 2016)
Table Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2015 and 2016)
Table Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2015 and 2016)
Figure Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2015 and 2016)
Table Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2015 and 2016)
Table Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2015 and 2016)
Table Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2015 and 2016)
Table Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2015 and 2016)
Table Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2015 and 2016)
Table Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Basic Information List
Table Bayer HealthCare Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer HealthCare Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table AngioCure Basic Information List
Table AngioCure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Table AngioCure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table AVIDAL Vascular GmbH Basic Information List
Table AVIDAL Vascular GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Table AVIDAL Vascular GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table AnGes MG Basic Information List
Table AnGes MG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Table AnGes MG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table Contego Medical Basic Information List
Table Contego Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Table Contego Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table Elixir Medical Basic Information List
Table Elixir Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Table Elixir Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table eucatech AG Basic Information List
Table eucatech AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Table eucatech AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table Lifetech Scientific Basic Information List
Table Lifetech Scientific Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Table Lifetech Scientific Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table Medtronic Basic Information List
Table Medtronic Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Table Medtronic Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table Micell Technologies Basic Information List
Table Micell Technologies Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Table Micell Technologies Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2012-2017)
Table Nipro Basic Information List
Table NuVascular Technologies Basic Information List
Table QT Vascular Basic Information List
Table QualiMed Innovative Medizinprodukte GmbH Basic Information List
Table Rontis Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Figure Manufacturing Process Analysis of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Figure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Industrial Chain Analysis
Table Raw Materials Sources of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Major Manufacturers in 2015
Table Major Buyers of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Table Distributors/Traders List
Figure Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate Forecast (2017-2022)
Figure Germany Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate Forecast (2017-2022)
Figure France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate Forecast (2017-2022)
Figure France Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate Forecast (2017-2022)
Figure UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate Forecast (2017-2022)
Figure UK Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate Forecast (2017-2022)
Figure Russia Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate Forecast (2017-2022)
Figure Italy Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate Forecast (2017-2022)
Figure Spain Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate Forecast (2017-2022)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Type (2017-2022)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Application (2017-2022)
Similar Reports
Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.
Nanomaterials possess nanoscale dimensions ranging from 1 to 100 nanometers. They occur naturally or can be engineered with specific properties such as size, shape, surface, and chemistry. Volcanic ash and forest fibers are some of the examples of natural nano...
- Publish Date: September 10, 2016
- $5820
Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...
- Publish Date: July 4, 2017
- $5370
